tiprankstipranks
Dyne Therapeutics (DYN)
NASDAQ:DYN
US Market
DYN
Dyne Therapeutics
RESEARCH TOOLSreports
Want to see DYN full AI Analyst Report?

Dyne Therapeutics (DYN) Stock News & Sentiment

458 Followers
Dyne Therapeutics: De-Risked DMD Opportunity, Pivotal DM1 Readout, and Emerging M&A Appeal Support Buy Rating
Premium
Ratings
Dyne Therapeutics: De-Risked DMD Opportunity, Pivotal DM1 Readout, and Emerging M&A Appeal Support Buy Rating
14d ago
DYN
Dyne Therapeutics Advances Pivotal DYNE-101 Trial in Myotonic Dystrophy Type 1
Premium
Company Announcements
Dyne Therapeutics Advances Pivotal DYNE-101 Trial in Myotonic Dystrophy Type 1
19d ago
DYN
Buy Rating on Dyne Therapeutics Driven by Robust Phase 3 DM1 Endpoint Strategy and Emerging Disease‑Modification Data
Premium
Ratings
Buy Rating on Dyne Therapeutics Driven by Robust Phase 3 DM1 Endpoint Strategy and Emerging Disease‑Modification Data
2M ago
DYN
Dyne Therapeutics Highlights Pipeline and Cash at JPM Conference
Premium
Company Announcements
Dyne Therapeutics Highlights Pipeline and Cash at JPM Conference
4M ago
8K
DYN
Dyne Therapeutics Appoints Vikram Karnani to Board
Premium
Company Announcements
Dyne Therapeutics Appoints Vikram Karnani to Board
4M ago
8K
DYN
Dyne Therapeutics Announces Upsized Public Offering
Premium
Company Announcements
Dyne Therapeutics Announces Upsized Public Offering
5M ago
8K
DYN
Dyne Therapeutics Amends Loan Agreement for $50 Million
Premium
Company Announcements
Dyne Therapeutics Amends Loan Agreement for $50 Million
5M ago
8K
DYN
More DYN News >

DYN News on the Web

Dyne Therapeutics Advances Pivotal DYNE-101 Trial in Myotonic Dystrophy Type 1
TipRanks News
Neutral
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
TipRanks News
Neutral
Why Dyne Therapeutics Stock Is Quietly Surging
TipRanks News
Bullish
Why Dyne Therapeutics Stock Is Sinking Today
TipRanks News
Bearish
Insider Scoop: Dyne Therapeutics Director Makes a Bold New Purchase
TipRanks News
Bullish
Insider Buying: Brian Posner Acquires Additional Shares of Dyne Therapeutics Inc (DYN)
GuruFocus News
Neutral
Dyne Therapeutics Stock Surges on Big Biotech Catalyst
TipRanks News
Bullish
Dyne Therapeutics Stock Slides After Rally Fizzles
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
DYN
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.25 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DYN’s Media Buzz Sentiment?
1 articles about DYN were published this week. In an average week, 2.25 articles are published.
    What is DYN’s weekly average amount of articles?
    In an average week, 2.25 articles about DYN are published.
      What is DYN’s News Sentiment?
      50% of articles about DYN were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week